Jourden-KY March 2026 Revenue NT$209 million (YoY -0.5%)
Key facts
- Jourden-KY March 2026 Revenue NT$209 million (YoY -0.5%)
- Jourden-KY's monthly revenue for March 2026 was NT$209 million, a slight decrease of 0.5% year-over-year. The company is classified in the biotechnology and medical care industry.
- Source: 臺灣證券交易所 TWSE
- Date: March 1, 2026
Direct answer
Jourden-KY's monthly revenue for March 2026 was NT$209 million, a slight decrease of 0.5% year-over-year. The company is classified in the biotechnology and medical care industry.
- Citation
- Jourden-KY March 2026 Revenue NT$209 million (YoY -0.5%) (March 1, 2026), 臺灣證券交易所 TWSE
- Source
- 臺灣證券交易所 TWSE
- Date
- March 1, 2026
Jourden-KY's monthly revenue for March 2026 was NT$209 million, a slight decrease of 0.5% year-over-year. The company is classified in the biotechnology and medical care industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 21:27 (4h 57m after Collected)
Jourden-KY (Stock Code: 4190), which operates in the biotechnology and medical care sector, announced its revenue for March 2026. The monthly revenue was 208,898 thousand NTD (approximately NT$209 million), representing a slight decrease of 0.5% compared to the same month last year.
FAQ
What are the key facts in this article?
Jourden-KY's monthly revenue for March 2026 was NT$209 million, a slight decrease of 0.5% year-over-year. The company is classified in the biotechnology and medical care industry.
What is the direct answer?
Jourden-KY's monthly revenue for March 2026 was NT$209 million, a slight decrease of 0.5% year-over-year. The company is classified in the biotechnology and medical care industry.
What is the source and date?
臺灣證券交易所 TWSE: https://openapi.twse.com.tw/revenue/twse-rev-4190-11503 | March 1, 2026